Karolinska University Hospital

19 articles about Karolinska University Hospital

• IntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s Disease

  7/25/2023

  IntelGenx Corp. today announced the execution of a Research Grant Agreement with Karolinska University Hospital and that the manufacturing of both active and placebo films are underway in preparation for a planned multicentre, randomized, double-blind, placebo-controlled clinical study (the “Study”) to investigate the use of IntelGenx’s Montelukast VersaFilm ® for the treatment of Parkinsons Disease.

• Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden

  2/1/2022

  Oncorena announced the initiation of the Phase I-II clinical trial of the first-in-class compound orellanine in patients with advanced kidney cancer on dialysis.

• IRRAS Announces Collaboration with Karolinska University Hospital

  1/12/2021

  Collaboration agreement with Neurosurgery Department of Karolinska University Hospital will further enhance the usage of the company's transformative IRRAflow system to benefit neurocritical care patients in Sweden

• Karolinska University Hospital Announces the First Treatment in the Nordic Region of a Brain Tumor With Laser Ablation

  10/2/2019

  On September 17th 2019 Karolinska University Hospital became the first hospital in the Nordic region to use laser ablation technique in the treatment of a patient with a brain tumor.

• Karolinska University Hospital Solna Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

  7/25/2019

  Varian announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate brachytherapy treatments using the new Bravos™ afterloader system.

• ZipLine Medical Announces New Emergency Department Study Showing Significant Time and Cost Savings, and Superior Patient Satisfaction, with Laceration Closure Using Zip® Surgical Skin Closure

  3/21/2019

  ZipLine Medical, Inc. announced presentation of positive results from a randomized, prospective clinical study conducted at the Karolinska University Hospital in Stockholm, Sweden demonstrating both clinical and economic benefits of the Zip® Surgical Skin Closure device when used in an emergency medicine setting for lacerations.

• Very Premature Babies At Greater Risk For Autism, Karolinska University Hospital Study

  12/29/2015

• Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™

  10/16/2014

• Royal Philips Electronics N.V. Partners With The Stockholm County Council And Karolinska University Hospital To Meet Future Demands Of Health Care

  5/7/2014

• Vitamin D Can Help Infection-Prone Patients Avoid Respiratory Tract Infection, Karolinska Institute and Karolinska University Hospital Study

  12/14/2012

• Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy

  5/22/2012

• Antidepressants While Pregnant Linked to Slight Risk of Lung Problem in Babies, Karolinska University Hospital Study

  1/13/2012

• Lab-Made Trachea Saves Man, Karolinska University Hospital Reveals

  7/8/2011

• Not All Heart Failure Drugs Boost Survival Equally, Karolinska University Hospital Study

  1/12/2011

• Smoking May Interfere With Rheumatoid Arthritis Treatment, Karolinska University Hospital Study

  1/6/2011

• Simpler And Cheaper Antibiotic Prophylaxis With Insertion Of Nutrition Catheter In The Stomach, Karolinska University Hospital Reveals

  7/6/2010

• Rituximab Safe Long-Term in RA, Karolinska University Hospital Study

  2/3/2010

• Anti-Tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In RA Patients, Karolinska University Hospital Study

  10/29/2009

• Infliximab Better than Oral DMARDs as Add-On to Methotrexate in Arthritis, Karolinska University Hospital And Karolinska Institute Study

  8/7/2009